… and doxorubicin for synergistic treatment. The prepared … of low molecular weight It limits the
uptake of the conjugates to the … to enhance the anticancer activity of the anticancer drugs with …

… with a high molecular weight to low molecular weight products … and doxorubicin, resulting
in synergistic anticancer activity, … dual combination therapy using polymer-drug conjugates …

… the growth of tumor synergistically. Polymer-drug conjugates based on hyaluronic acid were
… of aptamers over monoclonal antibodies include low molecular weight, long storage period, …

… Polymer–drug conjugate based delivery is a technique in … While, another drug of low-molecular-weight
(LMW) can be … (PDT) in combination with adriamycin against neuroblastoma …

… starch doxorubicin (HES-SS-DOX) conjugate developed for … Chitosan with low molecular
weight suppresses the growth … as a drug carrier, can induce synergistic effects. The cytotoxic …

… The low molecular weight drug molecules distribute rapidly in … , the conjugate showed superior
antitumor activity compared … age of the covalent conjugation of doxorubicin with chitosan (…

… of water-soluble macromolecules with low molecular weight drugs and selected proteins. …
a) Combination chemotherapy of backbone degradable polymer-drug conjugates with immune …

… including doxorubicin (topoisomerase inhibitor), camptothecin (… Curcumin, a low-molecular
weight polyphenol extracted from … that the polymer/drug combination increases apoptosis in …

… It also reported the utility of low molecular weight polymer … antitumor candidate for combination
therapy with doxorubicin. … The synergistic effect produced by the combination therapy …

… , increase the solubility of low molecular weight medicines, and … , doxorubicin, and gemcitabine
Hyaluronic acid Combination … and DOX that had synergistic anticancer activity. It was …